FIGURE

Fig. 2

ID

ZDB-FIG-230704-2

Publication

McKeown et al., 2022 - Pilot Study of Jadomycin B Pharmacokinetics and Anti-Tumoral Effects in Zebrafish Larvae and Mouse Breast Cancer Xenograft Models

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Jadomycin B inhibits proliferation of MDA-MB-231 cells in zebrafish larvae. MDA-MB-231 breast cancer cells were labelled with CellTracker? CM-Dil (yellow) fluorescent dye and transplanted into the yolk sacs of 48 h post-fertilization casper zebrafish larvae. CM-Dil positive larvae were treated with vehicle control (1:7 MeOH:H₂O), or jadomycin B at final concentrations of 10, 20, and 40 �mol/L. The fold change in MDA-MB-231 cells as determined by live cell imaging of zebrafish larvae 48 h post-treatment (hpt) (A). Error bars represent the mean � SEM (n = 20 larvae per group). *P < 0.05 compared to the vehicle control, one-way ANOVA followed by Bonferroni multiple comparison test. Representative brightfield (left) and accompanying fluorescent (right) imaging of live larvae comparing vehicle and 40 �m jadomycin B treatment at 72 hpt and 120 hpt (B). Images are representative of 20 treated larvae per group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Can. J. Physiol. Pharmacol.